AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
A "wakefulness-promoting agent" approved to improve wakefulness in patients with excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome (OSA/HS) and shaft work sleep disorder (SWSD). First approved in 1998 for improving wakefulness in narcolepsy.
* Recommended Dosage: 200 mg once a day, in the morning (for OSA/HS) or an hour before starting work shift (for SWSD).
* Special Considerations: Main side effects are headache, dizziness, nausea, and suppression of appetite initially, Starting at a lower dose (100 mg) and gradually increasing it over the first week helps minimize these effects, according to Dr. …